Author:
Cao Lu,Xu Cheng,Kirova Youlia M.,Cai Gang,Cai Rong,Wang Shu-Bei,Shen Kun-Wei,Ou Dan,Chen Jia-Yi
Funder
Clinical Research Plan of SHDC
Youth Foundation of Shanghai Health and Family Planning Commission
National Natural Science Foundation of China
National Key Research and Development Program of China
Publisher
Springer Science and Business Media LLC
Reference32 articles.
1. National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology. Breast Cancer, Version 1. 2018.
https://www.nccn.org/professionals/physician_gls/default.aspx
. Accessed 20 Mar 2018.
2. Cao L, Ou D, Shen KW, et al. Outcome of postmastectomy radiotherapy after primary systemic treatment in patients with clinical T1-2N1 breast cancer. Cancer Radiother. 2018;22(1):38–44.
3. Beriwal S, Shinde A, Rajagopalan MS, Kannan N, Heron DE, Deutsch M. Recommendations for post-mastectomy radiation therapy after neo-adjuvant chemotherapy: an International Survey of Radiation Oncologists. The Breast J. 2013;19(6):683–4.
4. White J, Mamounas E. Locoregional radiotherapy in patients with breast cancer responding to neoadjuvant chemotherapy: a paradigm for treatment individualization. J Clin Oncol. 2014;32(6):494–5.
5. Shim SJ, Park W, Huh SJ, et al. The role of postmastectomy radiation therapy after neoadjuvant chemotherapy in clinical stage II–III breast cancer patients with pN0: a multicenter, retrospective study (KROG 12-05). Int J Radiat Oncol Biol Phys. 2014;88(1):65–72.